Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS | 10 | - | +0,64 % | ||
| BIONTECH | 7 | 13 | +1,24 % | ||
| INTELLIA THERAPEUTICS | 5 | 5 | +0,92 % | ||
| BEONE MEDICINES LTD ADR | 4 | 10 | -0,64 % | ||
| AMGEN | 2 | 27 | -1,32 % | ||
| MODERNA | 2 | 16 | -2,20 % | ||
| REVOLUTION MEDICINES | 2 | 5 | -1,10 % | ||
| ILLUMINA | 2 | - | -1,50 % | ||
| BIOGEN | 1 | 54 | -1,82 % | ||
| REGENERON PHARMACEUTICALS | 1 | 22 | -1,60 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 00:24 | Bloom Energy surges on inclusion to S&P 500; Illumina, Everpure also added | 1 | Seeking Alpha | ||
| Fr | Index-Neugewichtung: Bloom Energy, Illumina und Everpure rücken in den S&P 500 auf | 2 | Investing.com Deutsch | ||
| Fr | Xenon (XENE) Heads To Europe With Data That Could Reshape Epilepsy Care | 2 | Insider Monkey | ||
| Fr | Ionis Pharmaceuticals falls after Pelacarsen fails key Phase 3 heart trial | 2 | Seeking Alpha | ||
| Fr | HARROW, INC. - 8-K, Current Report | - | SEC Filings | ||
| Fr | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Fr | Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run? | 5 | The Motley Fool | ||
| Fr | Intellia Therapeutics, Inc. - 8-K, Current Report | 6 | SEC Filings | ||
| Fr | Syndax Pharmaceuticals, Inc.: Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 4 | GlobeNewswire (USA) | ||
| Fr | Intellia Therapeutics, Inc.: Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 7 | GlobeNewswire (USA) | ||
| Fr | Spyre Therapeutics, Inc.: Spyre Therapeutics Announces Grants of Inducement Awards | 2 | GlobeNewswire (USA) | ||
| Fr | Vor Biopharma: Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 2 | GlobeNewswire (USA) | ||
| Fr | Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Fr | Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now? | 2 | The Motley Fool | ||
| Fr | Amneal Pharmaceuticals (AMRX) Bets Big On Biosimilars While Wall Street Retreats | 1 | Insider Monkey | ||
| Fr | BeOne (ONC) Secured a Pharmaceutical-Tariff Exemption After More than $1B of U.S. Manufacturing Investment. Are the Pricing Concessions Worth It? | 2 | Insider Monkey | ||
| Fr | FDA Fast Track Puts Erasca's (ERAS) Pancreatic Bet Center Stage | 1 | Insider Monkey | ||
| Fr | FDA Approves Ionis Pharma Drug, the First for Ultra-Rare Alexander Disease | 2 | MedCity News | ||
| Fr | Biontech besucht wichtige Konferenz | 556 | 4investors | Bei Biontech dürfte es in den kommenden Monaten eine Reihe von wichtigen Nachrichten geben. Vom 12. September bis 15. September findet in Seoul (Südkorea) die Weltlungenkrebskonferenz statt. Dort wird... ► Artikel lesen | |
| Fr | Revolution Medicines Got Its Breakthrough-What Moves It Next? | 4 | MarketBeat |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.